Innate Pharma SA Foreign Exchange Loss
Innate Pharma SA (IPHA) reported Foreign Exchange Loss of EUR 2.57 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2025-09-17
- 2025-06-30: Foreign Exchange Loss 6 month 2.57M EUR.
- 2024-06-30: Foreign Exchange Loss 6 month 1.76M EUR.
| Period end | Foreign Exchange Loss 6 month |
|---|---|
| 2025-06-30 | 2.57M EUR 6-K · filed 2025-09-17 |
| 2024-06-30 | 1.76M EUR 6-K · filed 2025-09-17 |